Page 6 - 2022_03-Haematologica-web

Complications in Hematology
635 Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia
Marion K. Mateos et al.
https://doi.org/10.3324/haematol.2020.268565
Hematopoiesis
644 Ddx41 inhibition of DNA damage signaling permits erythroid progenitor expansion in zebrafish Joshua T. Weinreb et al.
https://doi.org/10.3324/haematol.2020.257246
655 Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes Nathalie van Leeuwen-Kerkhoff et al.
https://doi.org/10.3324/haematol.2020.268136
Hemostasis
668 Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance Soracha E. Ward et al.
https://doi.org/10.3324/haematol.2020.274720
Myelodysplastic Syndromes
680 ZRSR1 co-operates with ZRSR2 in regulating splicing of U12-type introns in murine hematopoietic cells Vikas Madan et al.
https://doi.org/10.3324/haematol.2020.260562
Non-Hodgkin Lymphoma
690 Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma Man Chun John Ma et al.
https://doi.org/10.3324/haematol.2020.274258
702 Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma Armando N. Bastidas Torres et al.
https://doi.org/10.3324/haematol.2020.274506
715 Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies
Ronit Gurion et al.
https://doi.org/10.3324/haematol.2021.279216
Plasma Cell Disorders
721 The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myeloma Kanagaraju Ponnusamy et al.
https://doi.org/10.3324/haematol.2020.274480
Letters to the Editor
733 Early mortality and survival improvements for adolescents and young adults with acute promyelocytic leukemia in California: an updated analysis
Renata Abrahão et al.
https://doi.org/10.3324/haematol.2021.278851
737 Dual pyroptotic biomarkers predict erythroid response in lower-risk non-del(5q) myelodysplastic syndromes treated with lenalidomide and recombinant erythropoietin
Chen Wang et al.
https://doi.org/10.3324/haematol.2021.278855
haematologica Journal of the Ferrata Storti Foundation
Haematologica 2022; vol. 107 no. 3 - March 2022 http://www.haematologica.org/